CervoMed Inc.
CRVO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001053691
No open-market purchases or sales by CervoMed Inc. insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $5.42M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding CervoMed Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 45 | 1 | 45 | +1 |
| Shares | 2.17M | 26.1K | 2.13M | −14.7K (−0.7%) |
| Value | $13.7M | $164.0K | $17.3M | +$3.76M (+27.8%) |
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (13)
Institutions that held CervoMed Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 30,510 | $246.8K | 0.00% |
| Cetera Investment Advisers | 27,440 | $222.0K | 0.00% |
| Savvy Advisors, Inc. | 25,922 | $209.7K | 0.01% |
| Hilton Capital Management, LLC | 17,315 | $140.1K | 0.01% |
| Two Sigma Investments, LP | 17,108 | $138.4K | 0.00% |
| Readystate Asset Management LP | 14,534 | $117.6K | 0.01% |
| Gsa Capital Partners LLP | 11,307 | $91.0K | 0.01% |
| JPMorgan Chase & Co | 1,975 | $16.0K | 0.00% |
| TSFG, LLC | 300 | $2.00K | 0.00% |
| SRS Capital Advisors, Inc. | 32 | $258 | 0.00% |
| GAMMA Investing LLC | 30 | $243 | 0.00% |
| Optiver Holding B.V. | 10 | $81 | 0.00% |
| Northwestern Mutual Wealth Management Co | 1 | $8 | 0.00% |
Sold out (12)
Institutions that held CervoMed Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Jane Street Group, LLC | 65,939 | $414.4K |
| AQR Capital Management LLC | 22,804 | $143.3K |
| Goldman Sachs Group Inc | 21,199 | $133.2K |
| Susquehanna International Group, LLP | 13,075 | $82.2K |
| Marshall Wace, LLP | 12,017 | $75.6K |
| Squarepoint Ops LLC | 11,557 | $72.6K |
| HRT Financial LP | 10,434 | $65.0K |
| Caitong International Asset Management Co., Ltd | 906 | $5.69K |
| Wells Fargo & Company | 131 | $823 |
| EverSource Wealth Advisors, LLC | 36 | $226 |
| Essential Partners LLC | 7 | $44 |
| True Wealth Design, LLC | 5 | $32 |
Not filed for Q3 2025 yet (1)
Institutions that held CervoMed Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Avantax Advisory Services, Inc. | 26,087 | $164.0K |